TP53 and breast cancer: Melatonin suppresses the binding of estrogen to Erα, meaning that melatonin regulates the proliferation, invasion, protein levels, growth factor expression, and expression of proto-oncogenes, including hTERT, p53, p21, TGFβ, and E-cadherin, of estrogen-dependent breast cancer cells [72].